C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma
- 18 October 2018
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 96 (1) , 25-32
Abstract
The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated in about half of the HCC patients, limiting its usefulness in following the effects of therapy or screening. New markers are needed. It has been previously noted that the inflammation markers C-reactive protein (CRP) and platelet-lymphocyte ratio (PLR) are prognostically important and may reflect HCC aggressiveness. We therefore examined these 2 markers in a low-AFP HCC cohort and found that for HCCs > 2 cm, both markers significantly rise with an increasing maximum tumor diameter (MTD). We calculated the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and Youden index value for each marker, and their area-under-the-curve values for each MTD group. Patients were dichotomized into 2 groups based on the CRP and PLR from the receiver-operating characteristic curve analysis. In the logistic regression models of the 4 different MTD patient groups, CRP and PLR levels were statistically significant to estimate MTD in univariate logistic regression models of MTD groups > 2 cm. CRP and PLR were then combined, and the combination was statistically significant to estimate MTD groups of 3-, 4-, and 5-cm cutoffs. CRP and PLR thus have potential as tumor markers for low-AFP HCC patients, and possibly for screening.Keywords
This publication has 19 references indexed in Scilit:
- The systemic inflammatory response as a prognostic factor for advanced hepatocellular carcinoma with extrahepatic metastasisMolecular and Clinical Oncology, 2016
- C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic ReviewPLOS ONE, 2015
- Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinomaTumor Biology, 2014
- Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinomaHepatology, 2012
- Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinomaBritish Journal of Cancer, 2012
- Tumor‐related factors do not influence the prognosis of solitary hepatocellular carcinoma after partial hepatectomyJournal of Hepato-Biliary-Pancreatic Sciences, 2011
- Estimation of the Youden Index and its Associated Cutoff PointBiometrical Journal, 2005
- The impact of preoperative serum C‐reactive protein on the prognosis of patients with hepatocellular carcinomaCancer, 2005
- Diagnostic Usefulness of Acute-Phase Protein Measurement in Hepatocellular CarcinomaCancer Investigation, 1996
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978